Run-through
Cipla’s worldwide CEO Umang Vohra will step down in March 2026. Achin Gupta, presently worldwide COO, will take control of as the brand-new MD and GCEO from April 1, 2026. Gupta signed up with Cipla in 2021 and has actually contributed in driving development and reinforcing operations. He holds degrees from IIT Delhi and IIM Ahmedabad.
Drugmaker Cipla revealed on Thursday its international president and handling director, Umang Vohra, will step down, efficient March 2026. Vohra has actually worked as the MD & & GCEO of Cipla considering that 2016.
Achin Gupta, Cipla’s international chief running officer, will take control of the leading function from Vohra, with impact from April 1, 2026. The business has actually likewise designated him as an Additional Director.
Speaking on the event, Umang Vohra stated, “My 10 years at Cipla has actually been filled with enormous pride in what we’ve developed together. Directed by our function of Caring for Life, I have had the opportunity of dealing with enthusiastic groups who regularly put clients initially and drive development throughout business.”
He expressed gratefulness to chairman, Dr YK Hamied, and the company’s Board for their trust and support throughout this journey. “As I prepare tohand over the reins, I’m positive that Achin Gupta will lead Cipla forward with vision andpurpose. I eagerly anticipate supporting him and the management group to make sure a smoothtransition,” Vohra said.
Who is Achin Gupta, the new GCEO of Cipla?
Achin Gupta has been serving as the GCOO of the Company since February 2025. Under his role, he oversees Commercial markets, API, Manufacturing, and Supply Chain. He joined Cipla in 2021 as the CEOof the One India business and has been an integral member of the Management Council.
Gupta has driven strong growth, expanded Cipla’s reach in chronic therapies and underservedgeographies, and strengthened its core operations. Under his leadership, Cipla’s India businessdelivered market-leading profitability, modernized its retail force, and introduced consumer-focused innovations.
He also forged strategic global partnerships, positioning Cipla as apreferred innovation-led collaborator. With a M Tech degree from IIT Delhi, he spealizes in Biochemical Engineering and Biotechnology and also holds an MBA from IIM, Ahmedabad.
Speaking on his appointment as the next GCEO and MD, Achin Gupta said, “It is an honour to beentrusted with the responsibility of leading Cipla as its next MD & GCEO. Cipla’s legacy ofpurpose-driven innovation and patient-centric care is deeply inspiring, and I am committed tobuilding on the strong foundation laid by Umang and the leadership team.”
Remembering his experiences, he stated, “Over the past fewyears, I’ve had the privilege of working closely with teams across the organization andwitnessing firsthand the passion, resilience, and commitment that define Cipla. As we moveforward, my focus will remain on driving sustainable growth, deepening our impact acrossmarkets, and continuing to innovate with purpose.
The drugmaker has appointed Meera Vanjari, General Counsel (Designate) as the Global General Counsel and Senior Management Personnel of the Company with effect from April 1, 2026. She will succeed AS Kumar, Global General Counsel and SMP, who will complete his term in March 2026.
